2021
DOI: 10.1111/1754-9485.13164
|View full text |Cite
|
Sign up to set email alerts
|

Supplemental minimal‐activity PET/CT to validate ambiguous findings with less than 1 mSv: Proof of concept

Abstract: Summary Short‐term follow‐up examinations could verify ambiguous findings in PET/CT diagnostics, but are often avoided due to radiation and financial burdens. We demonstrate the feasibility of a focused, minimal‐activity PET protocol as a supplemental examination for uncertain findings after standard PET/CT. After changing conditions, e.g. patient positioning, preparation and bypassing an interval as well as a targeted tracer change, an additional examination with less than 1 mSv of additional radiation exposu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Furthermore, minimal-activity segmental PET/CT with application of 21 MBq 18 F-FDG was performed using a Biograph mCT40 scanner (Siemens Healthineers). 2 The additional hybrid sectional imaging examinations showed increased iodine (B1, white arrow) and glucose uptake (B2, white arrow) of a right-sided cervical lesion. Subsequently, we transferred the SPECT/CT and PET/CT data to a GE Logiq E9 US device (GE Healthcare, Milwaukee, WI) for the purpose of SPECT/US and PET/US fusion imaging.…”
Section: Figurementioning
confidence: 97%
See 1 more Smart Citation
“…Furthermore, minimal-activity segmental PET/CT with application of 21 MBq 18 F-FDG was performed using a Biograph mCT40 scanner (Siemens Healthineers). 2 The additional hybrid sectional imaging examinations showed increased iodine (B1, white arrow) and glucose uptake (B2, white arrow) of a right-sided cervical lesion. Subsequently, we transferred the SPECT/CT and PET/CT data to a GE Logiq E9 US device (GE Healthcare, Milwaukee, WI) for the purpose of SPECT/US and PET/US fusion imaging.…”
Section: Figurementioning
confidence: 97%
“…Because the topographical alignment between the planar scintigraphy and the several US findings remained unclear and the possibility of a lymph node metastasis was considered, we decided to perform additional cervical 131 I-SPECT/CT using a Symbia Intevo scanner equipped with a high-energy collimator (Siemens Healthineers, Erlangen, Germany). Furthermore, minimal-activity segmental PET/CT with application of 21 MBq 18 F-FDG was performed using a Biograph mCT40 scanner (Siemens Healthineers) 2 . The additional hybrid sectional imaging examinations showed increased iodine ( B1 , white arrow) and glucose uptake ( B2 , white arrow) of a right-sided cervical lesion.…”
mentioning
confidence: 99%